Liang J - Search Results

1

Tripeptide inhibitors of Yersinia protein-tyrosine phosphatase.

Lee K, Gao Y, Yao ZJ, Phan J, Wu L, Liang J, Waugh DS, Zhang ZY, Burke TR Jr. Lee K, et al. Among authors: liang j. Bioorg Med Chem Lett. 2003 Aug 4;13(15):2577-81. doi: 10.1016/s0960-894x(03)00481-5. Bioorg Med Chem Lett. 2003. PMID: 12852970

2

The role of protein-tyrosine phosphatase 1B in integrin signaling.

Liang F, Lee SY, Liang J, Lawrence DS, Zhang ZY. Liang F, et al. Among authors: liang j. J Biol Chem. 2005 Jul 1;280(26):24857-63. doi: 10.1074/jbc.M502780200. Epub 2005 May 2. J Biol Chem. 2005. PMID: 15866871 Free article.

3

Aurintricarboxylic acid blocks in vitro and in vivo activity of YopH, an essential virulent factor of Yersinia pestis, the agent of plague.

Liang F, Huang Z, Lee SY, Liang J, Ivanov MI, Alonso A, Bliska JB, Lawrence DS, Mustelin T, Zhang ZY. Liang F, et al. Among authors: liang j. J Biol Chem. 2003 Oct 24;278(43):41734-41. doi: 10.1074/jbc.M307152200. Epub 2003 Jul 29. J Biol Chem. 2003. PMID: 12888560 Free article.

4

PRL3 promotes cell invasion and proliferation by down-regulation of Csk leading to Src activation.

Liang F, Liang J, Wang WQ, Sun JP, Udho E, Zhang ZY. Liang F, et al. Among authors: liang j. J Biol Chem. 2007 Feb 23;282(8):5413-9. doi: 10.1074/jbc.M608940200. Epub 2006 Dec 27. J Biol Chem. 2007. PMID: 17192274 Free article.

5

Translational control of C-terminal Src kinase (Csk) expression by PRL3 phosphatase.

Liang F, Luo Y, Dong Y, Walls CD, Liang J, Jiang HY, Sanford JR, Wek RC, Zhang ZY. Liang F, et al. Among authors: liang j. J Biol Chem. 2008 Apr 18;283(16):10339-46. doi: 10.1074/jbc.M708285200. Epub 2008 Feb 11. J Biol Chem. 2008. PMID: 18268019 Free PMC article.

6

Stereospecific synthesis, structure-activity relationship, and oral bioavailability of tetrahydropyrimidin-2-one HIV protease inhibitors.

De Lucca GV, Liang J, De Lucca I. De Lucca GV, et al. Among authors: liang j. J Med Chem. 1999 Jan 14;42(1):135-52. doi: 10.1021/jm9803626. J Med Chem. 1999. PMID: 9888839

7

Nonsymmetric P2/P2' cyclic urea HIV protease inhibitors. Structure-activity relationship, bioavailability, and resistance profile of monoindazole-substituted P2 analogues.

De Lucca GV, Kim UT, Liang J, Cordova B, Klabe RM, Garber S, Bacheler LT, Lam GN, Wright MR, Logue KA, Erickson-Viitanen S, Ko SS, Trainor GL. De Lucca GV, et al. Among authors: liang j. J Med Chem. 1998 Jun 18;41(13):2411-23. doi: 10.1021/jm980103g. J Med Chem. 1998. PMID: 9632373

8

Design, synthesis, and evaluation of tetrahydropyrimidinones as an example of a general approach to nonpeptide HIV protease inhibitors.

De Lucca GV, Liang J, Aldrich PE, Calabrese J, Cordova B, Klabe RM, Rayner MM, Chang CH. De Lucca GV, et al. Among authors: liang j. J Med Chem. 1997 May 23;40(11):1707-9. doi: 10.1021/jm970081i. J Med Chem. 1997. PMID: 9171880

9

Evolocumab for early reduction of LDL-C levels in patients with acute ischemic stroke: a randomized controlled trial.

Qiu X, Liang Y, Wei Y, Lu M, Mei Y, Tang S, Tang J, Liang J, Liang J. Qiu X, et al. Among authors: liang j. Front Neurol. 2024 Dec 23;15:1454608. doi: 10.3389/fneur.2024.1454608. eCollection 2024. Front Neurol. 2024. PMID: 39764289 Free PMC article.

10

Sedated and unsedated gastroscopy has no influence on the outcomes of patients with gastric cancer: a retrospective study.

Yin C, Sun Y, Liang J, Sui X, He Z, Song A, Xu W, Zhang L, Sun Y, Zhao J, Han F. Yin C, et al. Among authors: liang j. BMC Cancer. 2025 Jan 6;25(1):13. doi: 10.1186/s12885-024-13413-0. BMC Cancer. 2025. PMID: 39762806 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18,213 results

Search Page

Filters